This FDA-cleared wearable neuromodulation system offers game-changing access for patients to start the road to recovery without interruptions to daily.
Life sciences company Ondine Biomedical reported a number of operational highlights in a first-quarter update on Monday, including clinical developments for US market approval, additional clinical data and endorsements, and commercial progress.